Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials

• Váldodahkkit: Xiang Zhao (Dahkki), Xubiao Ma (Dahkki), Xing Luo (Dahkki), Zhihua Shi (Dahkki), Ziwen Deng (Dahkki), Yuanxiang Jin (Dahkki), Zhipeng Xiao (Dahkki), Liming Tan (Dahkki), Pingfang Liu (Dahkki), Shilong Jiang (Dahkki), Yuanglu Shu (Dahkki), Bing Tang (Dahkki), Chengfeng Qiu (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2020-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Bempedoic acid is a new drug that reduces cholesterol synthesis via inhibiting ATP citrate lyase. It remains unclear whether the combination of bempedoic acid and other lipid-lowering drugs is better than these drugs alone. This study systematically reviewed the efficacy and safe...